Park EK , Warner N , Bong YS , Stapleton D , Maeda R , Pawson T , Daar IO .

	Figure 1. EphA4 mutants, their tyrosine phosphorylation state, and their kinase activity. Xenopus embryos were left uninjected or injected with RNA encoding wild type (WT) or various mutant EphA4 receptors. (A) Schematic representations of the kinase dead (KD, K653R), juxtamembrane tyrosine (Y596/602F), SAM domain deletion (ΔSAM), Y928F, and Y928E mutants are depicted. Embryos were harvested at stage 9, whole embryo lysates were immunoprecipitated with anti-EphA4 antibody and analyzed by Western blot analysis with antiphosphotyrosine antibodies (B) or in vitro kinase assays (C) were performed. SP, signal peptide; GD, globular ligand binding domain; TM, transmembrane domain; JM, juxtamembrane region; SAM, sterile alpha motif; PDZ, postsynaptic density protein, discs large, zona occludens binding motif.
	Figure 2. Comparison of EphA4 WT and EphA4 Y928F mutant expressing embryos. Embryos were left uninjected or injected with RNA encoding WT or Y928F mRNA. (A) Phenotypic effect and whole mount in situ hybridization with Xpo probe (posterior marker) of embryos expressing WT or Y928F mutant protein. Arrows indicate normal or ectopic posterior expression of the Xpo marker. (B) Summary of the frequency and percentage of Xenopus embryos displaying ectopic posterior structures when injected with either WT or Y928F EphA4 (number of embryos displaying protrusions/number of embryos injected). (C) WT or mutant EphA4 receptor expression was examined by Western blot analysis of stage 9 embryonic lysates. (D) Embryos stained for β-galactosidase activity after injection with mutant EphA4 receptor RNA plus β-galactosidase RNA or β-galactosidase RNA alone as a lineage tracer. Insert is enlargement of boxed area.
	Figure 3. Phenotypes and whole mount in situ hybridization of posterior and neural crest markers in Y928F injected embryos. (A) Cell dissociation at the blastula stage and ectopic protrusion formation at the stage 37/38 tadpole are observed in Y928F expressing embryos and not in uninjected controls. The arrow indicates a representative posterior protrusion. (B) Albino embryos were left uninjected or injected with Y928F mRNA (1.25 ng mRNA was injected into one blastomere at the 2-cell stage). Embryos at stage 26/28 were fixed with MEMPFA. Whole mount in situ hybridizations were performed with posterior markers (Xwnt3a and Xhox-3) and neural crest markers (Xslug and Xap-2). Filled arrowheads indicate staining of the posterior protrusions. Double-open arrowheads indicate third and fourth branchial arches; a single-open arrowhead denotes cephalic slug expression.
	Figure 4. Tyrosine phosphorylation state and kinase activity for various EphA4 Y928F double mutants. (A) Xenopus embryos were left uninjected or injected with RNA encoding the various Y928F double mutants depicted. (B) Embryos were harvested at stage 9 and the tyrosine phosphorylation state of the various EphA4 receptors was examined by IP-Western blot analysis. (C) In vitro kinase assays were performed on EphA4 immunoprecipitates to determine kinase activity of the various Y928F double mutants. (D) A Flag tag was introduced next to the signal peptide in ephrin binding domain mutants to create ΔGD-Flag-Y928F and ΔGD-Flag-Y928FKD mutants (noted in A). Various EphA4 mutants were immunoprecipitated with anti-Flag antibody and probed with antiphosphotyrosine antibody. Anti-EphA4 blots show equivalent levels of receptor expression. Abbreviations as in Figure 1.
	Figure 5. Morphological analysis and percentage of ectopic protrusions produced by the various Y928F double mutants. (A) Xenopus embryos were left uninjected or injected with RNA encoding the indicated Y928F double mutants. Photographs were taken at stage 26/28. Arrows indicate ectopic protrusions. Inset area represents dorsal view, and open arrowhead marks reference protrusion. (B) Embryos injected with Y928F RNA or Y928FY596/602E RNA were cultured and photographed at stage 9. (C) The frequency of the posterior protrusion phenotype was scored. Note: Both the Y928FM972K (Y928F SAM dimerization mutant) and Y928FY596/602E (Y928F juxtamembrane-SH2 binding mutant) induce budding protrusions (A and C), but Y928FY596/602E mutant does not induce cell dissociation (B).
	Figure 6. Activated FGFR1 induces ectopic posterior protrusions in whole embryos. (A) Morphology of embryos left uninjected or injected with 50 pg of an activated FGFR1 (actFGFR1). (B) Whole mount in situ hybridization analysis of ectopic protrusions produced by actFGFR1. Stage 26/28 embryos injected with actFGFR1 were fixed and probed with posterior markers (Xpo, Xwnt3a, and Xhox-3), neural crest marker (Xap-2), and FGF-8. Arrows indicate staining of ectopic protrusions by the indicated probes.
	Figure 7. EphA4 Y928F induces expression of eFGF, FGF-8, FGFR1, and FGFR4a. (A and B) Embryos were left uninjected or injected with Y928F mRNA (1 ng/embryo for A; 0.125 ng or 0.5 ng for B) into both blastomeres at the 2-cell stage. Animal caps were excised at stage 8 and cultured until stage 26 (A) or stage 10.5/11 (B). Expression of eFGF and FGF-8 were analyzed by RT-PCR. EF-1α was used to normalize cDNAs as a control. PCR reactions were performed in the absence of reverse transcriptase [RT(-)] as a negative control. A reaction performed using stage 26 (A) or stage 11 (B) whole embryo [WE RT (+)] RNA served as a positive control. (C) Analysis of ectopic protrusions by whole mount in situ hybridization of stage 26/28 embryos. Embryos left uninjected or injected with Y928F mRNA (2.5 ng/embryo) were fixed and probed with DIG-labeled FGF-8 (top three embryos), FGFR1 (middle three embryos), or FGFR4a (bottom three embryos). Arrowheads indicate staining of ectopic protrusions by the indicated probes.
	Figure 8. Inhibition of FGF-8 expression using antisense morpholino oligonucleotides represses Y928F-induced ectopic protrusion formation in vivo. (A) FGF-8-AS blocks translation of FGF-8 expression in vitro. HA-tagged FGF-8a or FGF-8b mRNAs (1 ng) were in vitro–translated in the presence or absence of FGF-8-AS (14 ng) or a control antisense reagent with 4 point mutations [FGF-8-AS-4PM] (14 ng) as indicated. Western blot analysis of the reaction products with anti-HA antibody was used to examine inhibition of FGF-8a and FGF-8b translation in the presence or absence of the indicated antisense reagent. The top and bottom arrows indicate the bands corresponding to FGF-8b and FGF-8a, respectively. (B) Antisense FGF-8 (FGF-8-AS) and (FGF-8-AS-4PM) were injected into the indicated number of Xenopus embryos with or without Y928F and scored for ectopic protrusions at stage 26.

Alfandari, ADAM 13: a novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development. 1997, Pubmed, Xenbase

Alfandari, ADAM 13: a novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development. 1997, Pubmed , Xenbase
Beck, A developmental pathway controlling outgrowth of the Xenopus tail bud. 1999, Pubmed , Xenbase
Beck, Analysis of the developing Xenopus tail bud reveals separate phases of gene expression during determination and outgrowth. 1998, Pubmed , Xenbase
Binns, Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. 2000, Pubmed
Boyd, Signals from Eph and ephrin proteins: a developmental tool kit. 2001, Pubmed
Brewster, Gli2 functions in FGF signaling during antero-posterior patterning. 2000, Pubmed , Xenbase
Chong, Fibroblast growth factor receptor-mediated rescue of x-ephrin B1-induced cell dissociation in Xenopus embryos. 2000, Pubmed , Xenbase
Christen, Spatial response to fibroblast growth factor signalling in Xenopus embryos. 1999, Pubmed , Xenbase
Davy, Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion. 1999, Pubmed
Dodelet, A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A. 1999, Pubmed
Durbin, Eph signaling is required for segmentation and differentiation of the somites. 1998, Pubmed
Ellis, A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn. 1996, Pubmed
Gale, Ephrins and their receptors: a repulsive topic? 1997, Pubmed
Gu, The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. 2001, Pubmed
Hama, SNT-1/FRS2alpha physically interacts with Laloo and mediates mesoderm induction by fibroblast growth factor. 2001, Pubmed , Xenbase
Hardcastle, FGF-8 stimulates neuronal differentiation through FGFR-4a and interferes with mesoderm induction in Xenopus embryos. 2000, Pubmed , Xenbase
Hemmati-Brivanlou, Inhibition of activin receptor signaling promotes neuralization in Xenopus. 1994, Pubmed , Xenbase
Henkemeyer, Nuk controls pathfinding of commissural axons in the mammalian central nervous system. 1996, Pubmed
Holland, Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. 1996, Pubmed
Holland, Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells. 1997, Pubmed
Kalo, Multiple in vivo tyrosine phosphorylation sites in EphB receptors. 1999, Pubmed
Kalo, Signal transfer by eph receptors. 1999, Pubmed
Kimelman, Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo. 1987, Pubmed , Xenbase
Kullander, Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo. 2001, Pubmed
MacArthur, FGF-8 isoforms differ in NIH3T3 cell transforming potential. 1995, Pubmed
Maeda, Xmeis1, a protooncogene involved in specifying neural crest cell fate in Xenopus embryos. 2001, Pubmed , Xenbase
Mayor, Induction of the prospective neural crest of Xenopus. 1995, Pubmed , Xenbase
Pandey, Characterization of a novel Src-like adapter protein that associates with the Eck receptor tyrosine kinase. 1995, Pubmed
Park, Low-molecular-weight protein tyrosine phosphatase is a positive component of the fibroblast growth factor receptor signaling pathway. 2002, Pubmed , Xenbase
Powers, Fibroblast growth factors, their receptors and signaling. 2000, Pubmed
Pownall, eFGF, Xcad3 and Hox genes form a molecular pathway that establishes the anteroposterior axis in Xenopus. 1996, Pubmed , Xenbase
Robbie, Temporal regulation of the Xenopus FGF receptor in development: a translation inhibitory element in the 3' untranslated region. 1995, Pubmed , Xenbase
Ruiz i Altaba, Bimodal and graded expression of the Xenopus homeobox gene Xhox3 during embryonic development. 1989, Pubmed , Xenbase
Sato, Localized and inducible expression of Xenopus-posterior (Xpo), a novel gene active in early frog embryos, encoding a protein with a 'CCHC' finger domain. 1991, Pubmed , Xenbase
Slack, Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. , Pubmed , Xenbase
Smalla, Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites. 1999, Pubmed
Smith, The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of branchial neural crest cells. 1997, Pubmed , Xenbase
Stapleton, The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. 1999, Pubmed
Stein, Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells. 1996, Pubmed
Stein, Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. 1998, Pubmed
Sun, Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. 1999, Pubmed
Tada, Analysis of competence and of Brachyury autoinduction by use of hormone-inducible Xbra. 1997, Pubmed , Xenbase
Thanos, Oligomeric structure of the human EphB2 receptor SAM domain. 1999, Pubmed
Wang, Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. 1998, Pubmed
Weinstein, FGF-mediated mesoderm induction involves the Src-family kinase Laloo. 1998, Pubmed , Xenbase
Winning, Disruption of cell adhesion in Xenopus embryos by Pagliaccio, an Eph-class receptor tyrosine kinase. 1996, Pubmed , Xenbase
Winning, EphA4 activity causes cell shape change and a loss of cell polarity in Xenopus laevis embryos. 2001, Pubmed , Xenbase
Winning, Pagliaccio, a member of the Eph family of receptor tyrosine kinase genes, has localized expression in a subset of neural crest and neural tissues in Xenopus laevis embryos. 1994, Pubmed , Xenbase
Winning, Developmental regulation of transcription factor AP-2 during Xenopus laevis embryogenesis. 1991, Pubmed , Xenbase
Wolda, Overlapping expression of Xwnt-3A and Xwnt-1 in neural tissue of Xenopus laevis embryos. 1993, Pubmed , Xenbase
Wybenga-Groot, Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. 2001, Pubmed
Xu, Expression of truncated Sek-1 receptor tyrosine kinase disrupts the segmental restriction of gene expression in the Xenopus and zebrafish hindbrain. 1995, Pubmed , Xenbase
Yu, Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor. 2001, Pubmed
Zisch, Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses. 2000, Pubmed
Zisch, Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region. 1998, Pubmed